CRIS Current Research Information System

DIEMBERGER, IGOR
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.990
EU - Europa 8.877
AS - Asia 4.945
AF - Africa 549
SA - Sud America 27
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 8
Totale 25.412
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.969
GB - Regno Unito 2.331
IT - Italia 1.845
CN - Cina 1.544
SG - Singapore 1.406
VN - Vietnam 1.221
DE - Germania 1.212
SE - Svezia 820
UA - Ucraina 640
RU - Federazione Russa 627
IN - India 537
IE - Irlanda 360
FR - Francia 357
EE - Estonia 198
CI - Costa d'Avorio 179
ZA - Sudafrica 156
FI - Finlandia 115
TG - Togo 112
BG - Bulgaria 97
CH - Svizzera 83
JO - Giordania 75
SC - Seychelles 59
NG - Nigeria 36
ID - Indonesia 35
AT - Austria 33
NL - Olanda 33
BE - Belgio 30
IR - Iran 27
HK - Hong Kong 25
GR - Grecia 23
JP - Giappone 23
CA - Canada 18
AU - Australia 15
KR - Corea 13
RO - Romania 13
CL - Cile 12
PL - Polonia 12
BR - Brasile 10
ES - Italia 6
EU - Europa 6
LB - Libano 6
LT - Lituania 6
DK - Danimarca 5
RS - Serbia 5
TR - Turchia 5
BD - Bangladesh 4
EG - Egitto 4
HR - Croazia 4
TH - Thailandia 4
AR - Argentina 3
NO - Norvegia 3
PT - Portogallo 3
SM - San Marino 3
TW - Taiwan 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MA - Marocco 2
SA - Arabia Saudita 2
VA - Santa Sede (Città del Vaticano) 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BZ - Belize 1
CO - Colombia 1
CY - Cipro 1
IQ - Iraq 1
LU - Lussemburgo 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PK - Pakistan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
VE - Venezuela 1
Totale 25.412
Salva come PNG Salva come JPEG
Città #
Southend 2.107
Fairfield 1.363
Singapore 1.237
Ashburn 938
Chandler 727
Woodbridge 670
Santa Clara 663
Wilmington 621
Seattle 575
Princeton 563
Houston 549
Dong Ket 497
Jacksonville 450
Cambridge 438
Dublin 360
Boardman 356
Ann Arbor 326
Westminster 231
Nanjing 208
Bologna 200
Padova 198
Abidjan 179
Berlin 171
Saint Petersburg 134
Milan 124
Jinan 122
Lomé 112
Shenyang 108
Rome 97
Beijing 95
Sofia 93
Helsinki 92
Medford 90
San Diego 89
Bremen 88
New York 82
Mülheim 79
Amman 75
Changsha 72
Turin 68
Nanchang 65
Hebei 64
Des Moines 61
Redmond 61
Bern 57
Mahé 57
Guangzhou 49
Jiaxing 46
Zhengzhou 42
Tianjin 41
Yubileyny 40
Olalla 38
Abeokuta 35
Jakarta 35
Ningbo 34
Bari 33
Dearborn 33
Hangzhou 33
Verona 31
Brussels 30
Shanghai 30
Taizhou 29
Bühl 26
Haikou 25
Norwalk 25
Nuremberg 25
Falls Church 23
Lappeenranta 23
London 23
Los Angeles 23
Florence 21
Hong Kong 21
Mountain View 21
Lanzhou 20
Phoenix 19
Tokyo 19
Hyderabad 17
Naples 17
Paris 17
Kunming 16
Pune 16
Redwood City 15
Taiyuan 15
Chicago 14
Vienna 14
Monterotondo 13
Chengdu 12
Monmouth Junction 12
Moscow 12
San Venanzo 12
Ardabil 11
Chongqing 11
Fuzhou 11
Hefei 11
Messina 11
Palermo 11
Catania 10
Columbus 10
Falkenstein 10
Kuban 10
Totale 16.813
Salva come PNG Salva come JPEG
Nome #
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 827
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system 235
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 224
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 193
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 183
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care 173
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 161
AF burden is important - Fact or fiction? 161
Automated CO2 angiography: Injection pressure and volume settings 161
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 160
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 156
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 154
Atrial fibrillation ablation: beyond electro-mechanical matters 150
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 149
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 148
'Real-World' antithrombotic treatment in atrial fibrillation: The eorp-af pilot survey 148
Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry 147
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 144
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 142
Cardiac resynchronization therapy in persistent left superior vena cava: Can you do it two-leads-only? 140
Farmaci antiaritmici 138
Electrocardiographic remodeling during cardiac resynchronization therapy 138
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 136
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads 136
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 134
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 133
Atrial fibrillation and heart failure: does one epidemic feed he other? 132
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 132
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 132
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia 131
Drug-induced Kounis syndrome: A matter of pharmacovigilance 130
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 129
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 128
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 127
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 127
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 127
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 126
Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients 124
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 124
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 123
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 123
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 122
The "Subtle" connection between development of cardiac implantable electrical device infection and survival after complete system removal: An observational prospective multicenter study 121
Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study 121
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 121
Cardioversione atriale interna: valutazione prospettica dei fattori determinanti il dolore indotto dallo shock. 117
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 117
La cardioversione elettrica nella pratica clinica:quali predittori di efficacia della procedura e di recidiva di fibrillazione/flutter atriale a lungo termine? 117
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. 116
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 115
Letter by Boriani et al regarding article, "Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study". 115
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: The EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry 115
Biventricular pacing in heart failure: what relationship between electrocardiographic and structural remodeling? 115
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response. 114
Cardiac resynchronization therapy and cardiac sympathetic function. 114
Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes 114
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 114
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 114
Atrial fibrillation in patients with a dual defibrillator: characteristics of spontaneous and induced episodes and effect of ventricular tachyarrhythmia induction. 113
Cardiac resynchronization therapy and VV interval optimization: which relationship between QRS width and the results of echo-guided VV interval optimization? 112
Balancing the Need for Personalization of QT Correction and Generalization of Study Results: Going Beyond Thorough QT Studies 112
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 112
Expenditure and value for money: the challenge of implantable cardioverter defibrillators 111
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 111
Role of drugs and devices in patients at risk of sudden cardiac death. 111
Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death 110
The QRS interval in patients treated with resynchronization therapy: which value 110
Implantation of cardioverter-defibrillator: Effects on shoulder function. 110
Is ventricular sensing always right, when it is left? 110
Meta-analysis of clinical outcomes of electrical cardioversion and catheter ablation in patients with atrial fibrillation and chronic kidney disease 110
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 109
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature 109
Atrial fibrillation: Adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction. 109
Outcomes with dronedarone in atrial fibrillation: What differences between real-world practice and trials? A meta-analysis and meta-regression analysis 109
Cardioversione elettrica di fibrillazione e flutter atriale: risultati a distanza. 108
Less is more: Can we achieve cardiac resynchronization with 2 leads only? 108
Cardiac resynchronisation therapy: effect on intra-ventricular and inter-ventricular dyssynchrony at radionuclide angiography by Fourier phase analysis 107
Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectives. 107
Cardioversione elettrica di fibrillazione atriale associata ad impianto di dispositivo per la resincronizzazione cardiaca: quali i risulatati a lungo termine? 106
Use of azithromycin and risk of ventricular arrhythmia 106
Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome. 106
Cardiac resynchronization therapy: update on clinical studies 106
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 105
Wireless Endocardial Atrial (and Ventricular) Sensing with no Implanted Power Source: a Proposal 105
Effetti emodinamici del pacing biventricolare a distanza di un anno dall'impianto 104
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 104
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 104
Phrenic stimulation: a challenge for cardiac resynchronization therapy 104
Corrected QT Interval Prolongation in Psychopharmacological Treatment and Its Modulation by Genetic Variation 104
Self-reported physical activity and major adverse events in patients with atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry 104
Is cardiac resynchronization therapy cost-effective? 103
The effects of gender on electrical therapies for the heart: physiology, epidemiology, and access to therapies 103
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 102
The challenge of preventing stroke in elderly patients with atrial fibrillation. 102
Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. 101
Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden. 101
Peri-operative management of patients taking antithrombotic therapy: need for an integrated proactive approach. 101
QRS pattern and improvement in right and left ventricular function after cardiac resynchronization therapy: a radionuclide study 100
Mechanisms of pain associated with internal defibrillation shocks: results of a randomized study of shock waveform. 100
Predictors of long-term survival free from relapses after extraction of infected CIED. 100
Totale 13.137
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.340
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.466 0 0 0 0 0 0 0 754 706 397 228 381
2020/20213.690 680 229 110 152 51 143 41 203 308 188 159 1.426
2021/20224.152 344 187 262 318 422 252 113 380 165 198 747 764
2022/20234.533 446 563 212 596 269 277 157 237 833 248 349 346
2023/20241.566 125 219 109 116 152 295 92 122 72 111 68 85
2024/20254.258 294 1.236 524 469 1.050 289 349 47 0 0 0 0
Totale 26.109